Trending
's Avatar

@edonato

102
Followers
454
Following
9
Posts
01.12.2024
Joined
Posts Following

Latest posts by @edonato

Post image

#EHA2025

12.06.2025 17:05 👍 1 🔁 0 💬 0 📌 0

Honoured to have been involved in this study and happy to see it finally published in @bloodjournal.bsky.social. Big Kudos to #DarjaKarpova and #HectorHuerbaEncabo for driving the project 🥇🥇🥇. Read full article here: ashpublications.org/blood/articl...

12.03.2025 20:27 👍 2 🔁 1 💬 0 📌 0

Congrats 🥂

11.02.2025 15:47 👍 1 🔁 0 💬 0 📌 0
Preview
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling Nature Cancer - Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the neuregulin...
21.01.2025 13:04 👍 0 🔁 0 💬 0 📌 0

🙏🙏Thanks🙏🙏@oncodaily.bsky.social and @elisabettabonzano.bsky.social for highlighting our recent paper on #HER3/NRG1 and #FGFR1 signaling in #CTC from #brestcancer patients published in @naturecancer.bsky.social @dkfz.bsky.social

Here the link 👇👇👇👇

rdcu.be/d61IZ

21.01.2025 13:04 👍 3 🔁 0 💬 1 📌 0
Universität Heidelberg Discontinues Communication Activities on Central X Account

www.uni-heidelberg.de/en/newsroom/...

13.01.2025 17:47 👍 6 🔁 2 💬 0 📌 1

Interested in understanding how #CTCs colonize distant organs and resist to therapy? Go check the latest paper from #RobertoWürth from #AndreasTrumpp lab on @naturecancer.bsky.social...
🚨SpoilerAlert: we can hijack those mechanisms to establish long term in vitro #CTC derived #organoids

10.01.2025 18:52 👍 5 🔁 1 💬 0 📌 0
Preview
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling Nature Cancer - Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the neuregulin...

Let's start the 2025 with a blast 🎇. Out today on @naturecancer.bsky.social Würth et al., on HER3/NRG1 and FGFR1 compensatory mechanism in CTCs and how to hijack that for long term in vitro culture.
#CTC #breastcancer #liquidbiopsies #NGS #personalizedmedicine @dkfz.bsky.social #HISTEM
rdcu.be/d5pGe

03.01.2025 18:49 👍 8 🔁 0 💬 0 📌 0
Preview
Bioinformatic Postdoc in Cancer Epigenomics

Are you interested in understanding non-genetic therapy resistance mechanisms in cancer? Do you have previous bioinformatic experience with single-cell epigenomic data analysis? Then consider applying to this postdoctoral position in our division:
jobs.dkfz.de/en/jobs/1673...

30.12.2024 09:07 👍 5 🔁 2 💬 0 📌 0

Join us at FMI as a Junior Group Leader! A unique opportunity to set up your lab in a vibrant international research institute with world-class research groups and facilities, generous core funding, a collegial and inclusive culture - and great colleagues 🤓!

16.12.2024 13:47 👍 42 🔁 35 💬 1 📌 0

Hello, can you also add me?

11.12.2024 07:53 👍 1 🔁 0 💬 0 📌 0
Preview
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype - Nature Genetics An integrated single-cell multiomic analysis of complex karyotype acute myeloid leukemia characterizes intratumoral heterogeneity and highlights links to therapeutic sensitivities.

Extremely proud to see my PhD project exploring intra-tumor heterogeneity in complex karyotype AML finally out in @NatureGenet! 🎉 👩🏻‍🔬

They say that 10,000 hours make you an expert, so I guess after more than five years of work I’m half-way there 😅 ⬇️1/5

www.nature.com/articles/s41...

25.11.2024 16:31 👍 27 🔁 10 💬 3 📌 0

Congrats Maija 😎🥳

10.12.2024 04:11 👍 1 🔁 0 💬 0 📌 0